Literature DB >> 19852143

Infective endocarditis in the Czech Republic: eight years of experience at one of the country's largest medical centers.

Michal Pazdernik1, Larry M Baddour, Radek Pelouch.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Limited data have been reported that characterize infective endocarditis (IE) in the Czech Republic. Hence, some local cases of IE were examined to provide a current profile of the disease in Central Europe.
METHODS: A descriptive case series of IE patients seen on all internal medicine services of a major teaching institution in the Czech Republic over an eight-year period was developed.
RESULTS: Prosthetic valves and rheumatic carditis were the underlying predisposing conditions in 18% and 17%, respectively, of all IE episodes. Staphylococcal species were the most common pathogens identified, and were present in 45% of IE episodes. In contrast, streptococcal species were recovered in only 14% of episodes. The proportion of culture-negative endocarditis cases was sizable (18%). The aortic valve was most commonly involved in IE episodes (47%), followed by the mitral valve (33%). The in-hospital mortality rate was 21%.
CONCLUSION: Younger patients, the occurrence of underlying rheumatic carditis, a lack of injection drug use, and an increased frequency of culture-negative infections are unique IE characteristics among Czech patients, as compared to those seen in patients from Western Europe and the United States. The heralded microbiological shift from viridans group streptococci to Staphylococcus aureus may apply to the current study.

Entities:  

Mesh:

Year:  2009        PMID: 19852143

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  6 in total

1.  Value of PCR in surgically treated patients with staphylococcal infective endocarditis: a 4-year retrospective study.

Authors:  B Zaloudíková; E Němcová; J Pol; Z Sorm; S Wurmová; K Novotná; M Vaněrková; V Holá; F Růžička; L Dušek; P Němec; T Freiberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

Review 2.  The causative agents in infective endocarditis: a systematic review comprising 33,214 cases.

Authors:  Christiana T Vogkou; Nikolaos I Vlachogiannis; Leonidas Palaiodimos; Antonis A Kousoulis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-11       Impact factor: 3.267

3.  Cardiac device-related infective endocarditis in the Czech Republic: Prospective data from the ESC EORP EURO-ENDO registry.

Authors:  Jan Latal; Michal Pazdernik; Maria Holicka; Radek Pelouch; Jiri Widimsky; Jiri Pudich; Radek Vancata; Michal Siranec; Kamila Blechova; Tadeas Butta; Marketa Mikulcova; Michal Mikulica; Peter Wohlfahrt; Martin Hutyra; Jan Precek
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-02-22       Impact factor: 1.245

Review 4.  Surgery in current therapy for infective endocarditis.

Authors:  Stuart J Head; M Mostafa Mokhles; Ruben L J Osnabrugge; Ad J J C Bogers; A Pieter Kappetein
Journal:  Vasc Health Risk Manag       Date:  2011-04-19

5.  The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease.

Authors:  Michael D Seckeler; Tracey R Hoke
Journal:  Clin Epidemiol       Date:  2011-02-22       Impact factor: 4.790

Review 6.  Infective endocarditis epidemiology over five decades: a systematic review.

Authors:  Leandro Slipczuk; J Nicolas Codolosa; Carlos D Davila; Abel Romero-Corral; Jeong Yun; Gregg S Pressman; Vincent M Figueredo
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.